Th1/Th2 cytokine profile in patients coinfected with HIV and Leishmania in Brazil

Clinical and Vaccine Immunology

Volumn 18, Issue 10, 2011, Pages 1765-1769

  Rodrigues, Maria Zilma Andrade ^a   Grassi, Maria Fernanda Rios ^b   Mehta, Sanjay ^c   Zhang, Xing Quan ^c   Gois, Luana Leandro ^b   Schooley, Robert T ^c   Badaro, Roberto ^a,c  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; PARASITE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MALE; MIXED INFECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SKIN LEISHMANIASIS; TH1 CELL; TH2 CELL;

BRAZIL; CELLS, CULTURED; CYTOKINES; HIV INFECTIONS; HUMANS; LEISHMANIASIS, CUTANEOUS; LEUKOCYTES, MONONUCLEAR; PLASMA; TH1 CELLS; TH2 CELLS;

EID: 80053440503     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00076-11     Document Type: Article

References (31)

1. Alvar, J., et al. 2008. The relationship between leishmaniasis and AIDS: the second 10 years. Clin. Microbiol. Rev. 21:334-359. (Pubitemid 351555511)
2. Amato, V. S., A. C. Nicodemo, J. G. Amato, M. Boulos, and V. A. Neto. 2000. Mucocutaneous leishmaniasis associated with HIV infection treated successfully with liposomal amphotericin B (AmBisome). J. Antimicrob. Chemother. 46:341-342. (Pubitemid 30639320)
3. Aukrust, P., et al. 1994. Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection - correlations to clinical, immunologic, and virologic parameters. J. Infect. Dis. 169:420-424. (Pubitemid 24045606)
4. Bacellar, O., A. D'Oliveira, Jr., S. Jeronimo, and E. M. Carvalho. 2000. IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis. Cytokine 12:1228-1231. (Pubitemid 30611800)
5. Bacellar, O., et al. 2002. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect. Immun. 70:6734-6740. (Pubitemid 35387904)
6. BD. 2010. BD cytometric bead array human Th1/Th2 cytokine instruction manual, vol. 551809. BD, Franklin Lakes, NJ.
7. + regulatory T cells control Leishmania major persistence and immunity. Nature 420:502-507.
8. Bio-Rad. 2010. Bio-plex suspension array system tech note 3157, p. 1-2. Bio-Rad Laboratories, Inc., Hercules, CA.
9. Bourreau, E., et al. 2003. Th2 responses predominate during the early phases of infection in patients with localized cutaneous leishmaniasis and precede the development of Th1 responses. Infect. Immun. 71:2244-2246. (Pubitemid 36368761)
10. Carvalho, E. M., R. Badaro, S. G. Reed, T. C. Jones, and W. D. Johnson, Jr. 1985. Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J. Clin. Invest. 76:2066-2069. (Pubitemid 16155495)
11. Carvalho, E. M., et al. 1985. Cell-mediated immunity in American cutaneous and mucosal leishmaniasis. J. Immunol. 135:4144-4148. (Pubitemid 16250404)
12. Cauda, R., et al. 1987. Diminished interferon gamma production may be the earliest indicator of infection with the human immunodeficiency virus. Viral Immunol. 1:247-258.
13. Cruz, I., et al. 2006. Leishmania/HIV coinfections in the second decade. Indian J. Med. Res. 123:357-388.
14. Gomes-Silva, A., et al. 2007. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? Clin. Exp. Immunol. 149:440-444. (Pubitemid 47256154)
15. Guimaraes, L. H., et al. 2009. Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil. Trans. R. Soc. Trop. Med. Hyg. 103:712-715.
16. Hardy, G. A., et al. 2003. Reconstitution of CD4+ T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsiveness. Clin. Exp. Immunol. 134:98-106. (Pubitemid 37186594)
17. Holaday, B. J., et al. 1993. Potential role for interleukin-10 in the immunosuppression associated with kala azar. J. Clin. Invest. 92:2626-2632. (Pubitemid 24006526)
18. Imami, N., C. Antonopoulos, G. A. Hardy, B. Gazzard, and F. M. Gotch. 1999. Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapy. AIDS Res. Hum. Retroviruses 15:1499-1508.
19. Lindoso, J. A., et al. 2009. Unusual manifestations of tegumentary leishmaniasis in AIDS patients from the New World. Br. J. Dermatol. 160:311-318.
20. Mattos, M., et al. 1998. American cutaneous leishmaniasis associated with HIV infection: report of four cases. J. Eur. Acad. Dermatol. Venereol. 10:218-225. (Pubitemid 28238508)
21. Pirmez, C., et al. 1993. Cytokine patterns in the pathogenesis of human leishmaniasis. J. Clin. Invest. 91:1390-1395. (Pubitemid 23127337)
22. Posada-Vergara, M. P., et al. 2005. Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS. J. Infect. Dis. 192:1819-1822. (Pubitemid 41587835)
23. Rabello, A., M. Orsini, and J. Disch. 2003. Leishmania/HIV co-infection in Brazil: an appraisal. Ann. Trop. Med. Parasitol. 97(Suppl. 1):17-28.
24. Redhu, N. S., A. Dey, V. Balooni, and S. Singh. 2006. Leishmania-HIV co-infection: an emerging problem in India. AIDS 20:1213-1215. (Pubitemid 43786119)
25. Rosatelli, J. B., C. S. Souza, F. A. Soares, N. T. Foss, and A. M. Roselino. 1998. Generalized cutaneous leishmaniasis in acquired immunodeficiency syndrome. J. Eur. Acad. Dermatol. Venereol. 10:229-232. (Pubitemid 28238510)
26. Schraner, C., et al. 2005. Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1. Clin. Infect. Dis. 40:e120-e124.
27. Turgay, N., I. C. Balcioglu, S. O. Toz, Y. Ozbel, and S. L. Jones. 2010. Quantiferon-Leishmania as an epidemiological tool for evaluating the exposure to Leishmania infection. Am. J. Trop. Med. Hyg. 83:822-824.
28. Valdez, H., et al. 2000. Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitorcontaining regimen. ACTG 375 team. AIDS Clinical Trials Group. AIDS 14:11-21. (Pubitemid 30072073)
29. Wendland, T., et al. 1999. HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia. AIDS 13:1857-1862. (Pubitemid 29509544)
30. Wolday, D., N. Berhe, H. Akuffo, and S. Britton. 1999. Leishmania-HIV interaction: immunopathogenic mechanisms. Parasitol. Today 15:182-187. (Pubitemid 29222736)
31. Wolday, D., N. Berhe, S. Britton, and H. Akuffo. 2000. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani. AIDS 14:921-929. (Pubitemid 30336052)